Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Zofenopril
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Trade names | Zocardis (RU) |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H23NO4S2 |
Molar mass | 429.55 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Zofenopril (INN) is a medication that protects the heart and helps reduce high blood pressure. It is an angiotensin-converting enzyme (ACE) inhibitor.
In small studies, zofenopril appeared significantly more effective in reducing hypertension than two older antihypertensive drugs, atenolol and enalapril, and was associated with fewer adverse effects.
Zofenopril is a prodrug with zofenoprilat as the active metabolite.
It was patented in 1978 and approved for medical use in 2000.
ACE inhibitors ("-pril") |
|
---|---|
AIIRAs ("-sartan") |
|
Renin inhibitors ("-kiren") |
|
Dual ACE/NEP inhibitors | |
Neprilysin inhibitors | |
|